The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1 - PubMed (original) (raw)
Comparative Study
. 1996 Jun 20;12(12):2579-94.
Affiliations
- PMID: 8700517
Comparative Study
The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1
M Vairapandi et al. Oncogene. 1996.
Abstract
Towards dissecting the regulation of terminal differentiation, including growth arrest and apoptosis, myeloid differentiation primary response (MyD) genes, induced in the absence of de novo protein synthesis following induction of M1 myeloblastic leukemia cells for terminal differentiation have been isolated. MyD118 was one of the novel MyD genes cloned, subsequently observed also to be a primary response gene to TGF-beta, which induces M1 cells for growth arrest and apoptosis uncoupled from differentiation. The MyD118 encoded protein was observed to be remarkably similar to the protein encoded by Gadd45, a growth arrest and DNA damage induced gene, regulated in part by the tumor suppressor p53. Though evidence has accumulated that MyD118 functions as an important modulator of negative growth control both in hematopoietic and non-hematopoietic cells, its mechanism of action is unknown. To better understand the role(s) of MyD118 in negative growth control, we have analysed the expression and biological characteristics of the MyD118 protein, compared to the Gadd45 protein, in distinct pathways of growth arrest and apoptosis, including p53 dependent and independent pathways either coupled or uncoupled from differentiation. It is shown that MyD118 and Gadd45 differentially accumulated upon induction of distinct pathways of growth arrest and apoptosis; notably, MyD118, but not Gadd45, was induced by TGF-beta, whereas Gadd45, but not MyD118, was induced by activating wild type (wt) p53 function. It is also shown that MyD118 is a nuclear protein, which regardless of the pathway induced, predominantly localized within the cell nucleus, and interacted with the DNA replication and repair protein PCNA and the cyclin dependent kinase inhibitor P21WAF1/CIP1. MyD118 also modestly stimulated DNA repair in vitro. All of these characteristics were shared with Gadd45. Finally, it is demonstrated that MyD118, Gadd45 and p21 synergized in the suppression of colony formation by NIH3T3 cells. Taken together, these findings demonstrate that MyD118 and Gadd45 are representative of a new protein family that share remarkable functional similarities in the control of distinct pathways of negative growth, including the suppression of cellular growth and programmed cell death.
Similar articles
- Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA, Hoffman B. Liebermann DA, et al. Stem Cells. 1994 Jul;12(4):352-69. doi: 10.1002/stem.5530120402. Stem Cells. 1994. PMID: 7951003 Review. - CR6: A third member in the MyD118 and Gadd45 gene family which functions in negative growth control.
Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K, Hoffman B, Liebermann DA. Zhang W, et al. Oncogene. 1999 Sep 2;18(35):4899-907. doi: 10.1038/sj.onc.1202885. Oncogene. 1999. PMID: 10490824 - PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C, Demetris AJ, Michalopoulos GK, Zhan Q, Shelhamer JH, Wu T. Han C, et al. Hepatology. 2003 Jul;38(1):167-77. doi: 10.1053/jhep.2003.50296. Hepatology. 2003. PMID: 12829999 - MyD genes in negative growth control.
Liebermann DA, Hoffman B. Liebermann DA, et al. Oncogene. 1998 Dec 24;17(25):3319-29. doi: 10.1038/sj.onc.1202574. Oncogene. 1998. PMID: 9916994 Review.
Cited by
- Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B. Vlach J, et al. EMBO J. 1996 Dec 2;15(23):6595-604. EMBO J. 1996. PMID: 8978686 Free PMC article. - New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L, Sun QF, Xu TY, Wu YH, Zhang H, Fu RQ, Cai FJ, Zhou QQ, Zhou K, Du QW, Zhang D, Xu S, Ding JG. Hong L, et al. World J Gastroenterol. 2016 Mar 7;22(9):2779-88. doi: 10.3748/wjg.v22.i9.2779. World J Gastroenterol. 2016. PMID: 26973416 Free PMC article. - Position-dependent expression of GADD45alpha in rat brain tumours.
Brú A, del Fresno C, Soares-Schanoski A, Albertos S, Brú I, Porres A, Rollán-Landeras E, Dopazo A, Casero D, Gómez-Piña V, García L, Arnalich F, Alvarez R, Rodríguez-Rojas A, Fuentes-Prior P, López-Collazo E. Brú A, et al. Med Oncol. 2007;24(4):436-44. doi: 10.1007/s12032-007-0025-9. Med Oncol. 2007. PMID: 17917095 - Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
Huether A, Hopfner M, Sutter AP, Baradari V, Schuppan D, Scherubl H. Huether A, et al. World J Gastroenterol. 2006 Aug 28;12(32):5160-7. doi: 10.3748/wjg.v12.i32.5160. World J Gastroenterol. 2006. PMID: 16937526 Free PMC article. - GADD45β mediates p53 protein degradation via Src/PP2A/MDM2 pathway upon arsenite treatment.
Yu Y, Huang H, Li J, Zhang J, Gao J, Lu B, Huang C. Yu Y, et al. Cell Death Dis. 2013 May 16;4(5):e637. doi: 10.1038/cddis.2013.162. Cell Death Dis. 2013. PMID: 23681232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous